Opinion: STAT readers on mask bans, cancer screening, and empathy and AI
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences…
Category: cancer
Opinion: Doing more cancer screening won’t reduce Black-white health disparities
For years, Black Americans have been more likely to die of cancer than white Americans….
Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses
The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients,…
Abortion, shingles, extreme heat, and sudden cardiac arrest
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Grail announces layoffs as it looks to push forward blood-based cancer detection test
Cancer detection firm Grail announced sizable workforce cuts on Tuesday in a bid to save…
As Covid deaths drop, heart disease and cancer remain leading causes of death
Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes…
Scientists are starting to uncover how neighborhood can affect the biology of cancer
Where you live has a relationship to your odds of getting cancer and surviving cancer….
Opinion: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow
The promise of scientific and medical innovation often comes with a downside: improvements in care…
STAT+: FDA approves innovative T cell immunotherapy for rare soft-tissue cancer
LONDON — U.S. regulators have authorized a cutting-edge treatment relying on T cells for a…
Morning Rounds: Inside the making of the first malaria vaccine
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Opinion: Rising rates of skin cancer: The cost of FDA’s inaction on novel sunscreen products
A decade after Sen. Jack Reed (D-R.I.) authored the Sunscreen Innovation Act, which became law…
With Biden’s departure in sight, advocates seek to preserve gains of Cancer Moonshot
In President Biden’s address to the nation after dropping out of the election race, he…
STAT+: Parasite engineered to treat brain development disorder in mice shows potential in study
The human body works hard to prevent outside substances from entering the brain — which…
Morning Rounds: Would a bird flu vaccine for cows work?
Want to stay on top of health news? Sign up to get our Morning Rounds…
STAT+: In a big step for liquid biopsy, FDA approves a blood test for colorectal cancer
The Food and Drug Administration on Monday approved a blood test intended to detect colon…
Morning Rounds: Three new bird flu cases in humans brings total to 13 in U.S.
Want to stay on top of health news? Sign up to get our Morning Rounds…
How Kamala Harris’ views on health care were shaped by her mother, cancer researcher Shyamala Gopalan
As Vice President Kamala Harris emerges as the likely Democratic candidate in the U.S. presidential…
Frontline: Heart Failure Detection in Women; Cancer Treatment; UTI Treatment Improvements
New MRI Method Improves Heart Failure Detection in Women Researchers have refined the use of…
Breast cancer study reveals a paradox of mastectomy
Breast cancer surgeons have tended not to push patients towards bilateral mastectomy, since data have…
STAT+: Novartis hedges on when it might submit myelofibrosis drug for approval
LONDON — A Novartis executive on Thursday said “it’s too early to say” whether the…
Bone marrow donors needn’t be perfect match, study says, paving way for more equitable access
As a hematologist-oncologist in Miami, Mikkael Sekeres always hopes his patients will find a perfect…
STAT+: A cancer care startup is making a new bet with payers and providers: only pay if it works
A cancer care navigation startup has raised $95 million from prominent tech investors to help…
Q&A: Why more info can lead some women to prefer delaying first mammogram
The messaging around mammography often doesn’t go beyond this simple three-word refrain: screening saves lives….
Element Biosciences raises another massive round
Want to stay on top of the science and politics driving biotech today? Sign up to get…
CAR-T therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies
Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T…
Alcohol is driving a half-dozen types of cancer in the U.S., study finds
Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives…
STAT+: Roche’s TIGIT study was a bust. What’s the outlook for its next big bet?
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
.jpg)
Medicaid is paying millions for salty, fat-laden ‘medically tailored’ cheeseburgers and sandwiches
WASHINGTON – They’re marketed as healthy, “dietitian-approved” meals and delivered directly to the homes of…
A rare voice box transplant helped a cancer patient speak again, part of a pioneering study
WASHINGTON (AP) — A Massachusetts man has regained his voice after surgeons removed his cancerous…
STAT+: A faster, simpler, cheaper cancer cell therapy is about to be tested in humans
In a long-awaited study, patients in Australia will soon receive an IV infusion designed to…
The biotech news you missed this week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
GLP-1s lower risk of 10 obesity-associated cancers, study shows
New research found that the GLP-1 class of drugs — glucagon-like peptide receptor agonists —…
STAT+: The biotech scorecard for the third quarter: 19 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third…
House panel passes bills to expand Medicare obesity drug coverage, cancer screening
WASHINGTON — A House committee overwhelmingly passed four bills on Thursday that would expand Medicare…
Exclusive: European VC Forbion hires Dyne CEO, expands into US
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Precision Medicine Personalizes Treatment
In the rapidly evolving landscape of modern health care, precision medicine stands out as a…
Your Genetic Profile: A Guide to Disease Prevention and Treatment
Precision medicine is a type of health care that involves basing a patient’s treatment on…
Hormone Replacement Therapy May Be Less Risky Than You Think
Hormone therapy (HT) works well to ease common menopause symptoms such as hot flashes, night…
STAT+: Journal retracts study tied to Micronoma’s effort to create blood cancer test
Nature retracted a high-profile paper that served as part of the scientific groundwork for Micronoma,…
News Briefs July 2024
Cannabis Use Linked to Higher Heart Attack and Stroke Risk A study published in the…
WHO warns global health toll of alcohol remains ‘unacceptably high’
The global health toll of alcohol remains “unacceptably high” across the globe, the World Health…
STAT+: Grail, aiming to launch a blood test for cancer, faces host of challenges as it debuts on Nasdaq
On Tuesday, shares of Grail, the liquid biopsy company that hopes that its test, Galleri,…
The findings from Alnylam’s highly anticipated readout
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Hank Green on his ‘Pissing Out Cancer’ comedy special, ulcerative colitis, and the jokes that got cut
There’s a website dedicated to asking how many days it’s been since Hank Green started…
Can JAK inhibitors bolster checkpoint inhibitors?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: New immunotherapy combination could ‘change the landscape’ of cancer treatment
When they work, immunotherapy drugs called checkpoint inhibitors can shrink cancers and, in some cases,…
STAT+: Oncologists turn to blood test for circulating tumor DNA, but questions remain on how to use the data
The hope for many cancer patients who go through surgery is that they’ll be cured…
STAT+: Oncologists turn to blood test for circulating tumor DNA, but questions remain on how to use the data
The hope for many cancer patients who go through surgery is that they’ll be cured…
STAT+: Will Geron be acquired? The long-short view
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
NIH wanted to make cancer research more diverse. The effort turned out to be a costly failure
Government researchers hoped to attract a more diverse group of patients for clinical research by…